Cardinal Health Expands Ability to Make Molecular Imaging Agents

By

MedCity News — Cardinal Health Inc. (NYSE: CAH) will manage and operate the Knoxville, Tennessee, cyclotron facility of ProVision Healthcare through an agreement that expands the Dublin, Ohio, drug distributor’s ability to make molecular imaging agents nationwide. Ohio’s largest corporation has been partnering with academia and industry to push the boundaries of nuclear medicine — and have first dibs on commercializing the industry’s innovations — by using its know-how and technologies to enable researchers to come up with new products. Read more at MedCityNews.com.